Abstract 3570: Prospects for Personalized Cancer Vaccines: the Oncolytic and Immunotherapeutic HSV-1(VC2) Virus Expressing an Ovalbumin (OVA) Antigen Elicits Robust Anti-Ova Immune Responses

Cancer research(2022)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要